Purdue, Sacklers Facing Fight Over Attempt to Evade Lawsuits
- States, cities want drugmaker and family to still stand trial
- Judge to rule on Purdue request to freeze 2,600 pending cases
Photographer: George Frey/Bloomberg
This article is for subscribers only.
Purdue Pharma LP and its owners, the billionaire Sackler family, shouldn’t get to use bankruptcy to dodge litigation over the drug maker’s role in the U.S. opioid crisis, two dozen states told a judge.
The company’s request to block 2,600 lawsuits would trample the right of state and local authorities to pursue claims that it used deceptive marketing for years to expand sales of its addictive painkiller OxyContin, state attorneys general said in a filing Friday in U.S. Bankruptcy Court in New York.